Eric Williams Medical Sciences Complex
Port of Spain, North Central, 00000, Trinidad and Tobago
NCT Number: NCT05547022
The purpose of this study was to investigate limb salvage rates in patients with critical limb ischemia after endovascular revascularization.
Looking for future studies?
Notify Me33 year–89 year
All sexes
Observational
Port of Spain, North Central, 00000, Trinidad and Tobago
A retrospective analytical study assessing limb salvage attempts and outcomes in 157 consecutive patients with CLI and tissue loss. It was for the period of May 2018 and May 2021 at Eric Williams Medical Sciences Complex.
The objectives of this study include Primary: To determine the success rate of target lesion revascularisation using endovascular limb salvage techniques in Critical limb ischemia patients with minor and major tissue loss.
Secondary objectives included:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
CLI patient with tissue loss who underwent infra inguinal endovascular limb salvage
Exclusion criteria
CLI patients with tissue loss who had surgical bypass CLI patients with no tissue loss
Peripheral vascular angioplasty or stenting
Time frame: 2 to 3 years
to determine the success rate of target lesion revascularization using endovascular limb salvage techniques
Time frame: 2 to 3 years
to assess the maintenance of amputation free survival and bipedal ambulation
Time frame: 2 to 3 years
to evaluate primary patency rate
Naveen Seecheran
Other
Critical Limb Ischemia in Trinidad and Tobago- A Series of 157 Endovascular Limb Salvage Attempts in Patients With CLTI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04229563
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT04089943
Arterial Occlusive Diseases, Arteriosclerosis
Austin, Texas, United States
View Trial DetailsNCT02685098
Amputation, Arterial Occlusive Disease
Indianapolis, Indiana, United States
View Trial DetailsNCT04440839
Arterial Occlusive Diseases, Arteriosclerosis
Sacramento, California, United States
View Trial Details